Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$3.69 - $7.09 $59,409 - $114,149
-16,100 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$3.58 - $7.44 $57,638 - $119,784
16,100 New
16,100 $120,000
Q1 2020

May 06, 2020

SELL
$3.49 - $9.2 $130,526 - $344,080
-37,400 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$4.75 - $8.38 $53,675 - $94,694
11,300 Added 43.3%
37,400 $262,000
Q2 2019

Aug 14, 2019

BUY
$6.4 - $10.94 $3,840 - $6,564
600 Added 2.35%
26,100 $185,000
Q1 2019

May 13, 2019

BUY
$6.1 - $10.3 $35,380 - $59,740
5,800 Added 29.44%
25,500 $263,000
Q4 2018

Feb 11, 2019

BUY
$5.84 - $11.92 $18,104 - $36,952
3,100 Added 18.67%
19,700 $122,000
Q2 2018

Aug 03, 2018

BUY
$18.75 - $28.46 $311,250 - $472,436
16,600 New
16,600 $464,000

Others Institutions Holding OPTN

About OptiNose, Inc.


  • Ticker OPTN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 83,277,504
  • Market Cap $440M
  • Description
  • OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...
More about OPTN
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.